As out-of-pocket costs rise for medicines used to treat certain neurologic disorders — such as dementia and neuropathy — patients are less likely to take their drugs as often as prescribed, according to a new study. And the findings are the latest indication that increasing drug costs may lead to worsening health and, consequently, higher health care expenses in the future.

Specifically, when out-of-pocket costs rose by $50 for a 30-day supply of medicines, there was a lower rate of patient adherence, a term used to describe the extent to which someone takes a medicine or follows medical advice as prescribed. For instance, there was a 9% drop in adherence for drugs used to treat neuropathy and a 12% decline in adherence for medicines used to combat dementia.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy